BioLineRx Ltd. - Ordinary Shares, par value NIS 0.10 per share (BLRX) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2024 to Q4 2025

Type / Class
Equity / Ordinary Shares, par value NIS 0.10 per share
Symbol
BLRX on Nasdaq
Shares outstanding
2,402,091,667
Price per share
$3.09
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
47,750
Total reported value
$135,626
% of total 13F portfolios
0%
Share change
+18,655
Value change
+$53,947
Number of holders
13
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of BioLineRx Ltd. - Ordinary Shares, par value NIS 0.10 per share (BLRX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
HIGHBRIDGE CAPITAL MANAGEMENT LLC 7.2% $818,056,338 172,950,600 Highbridge Capital Management, LLC 30 Jun 2025

As of 31 Dec 2025, 13 institutional investors reported holding 47,750 shares of BioLineRx Ltd. - Ordinary Shares, par value NIS 0.10 per share (BLRX). This represents 0% of the company’s total 2,402,091,667 outstanding shares.

Institutional Holders of BioLineRx Ltd. - Ordinary Shares, par value NIS 0.10 per share (BLRX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 47,750 $135,626 +$53,947 $2.77 13
2025 Q3 27,595 $104,308 -$179,717 $3.78 13
2025 Q2 66,216 $302,103 +$267,703 $4.57 17
2025 Q1 9,460 $27,997 +$18,523 $2.96 12
2024 Q4 20,064 $4,294 +$4,294 $0.21 1